Y C Woo1, B M Y Cheung1,2, C Y Yeung1, C H Lee1, E Y L Hui1,2, C H Y Fong2, A W K Tso2, S Tam3, K S L Lam1,2. 1. Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China. 2. Department of Medicine, The University of Hong Kong, Hong Kong, China. 3. Division of Clinical Biochemistry, Queen Mary Hospital, Hong Kong, China.
Abstract
AIMS: To investigate the usefulness of the additional measurement of HbA1c , compared with performing only the oral glucose tolerance test (OGTT), in identifying participants at increased cardiometabolic risk, in an urban Chinese population. METHODS: All participants from the fourth visit of the population-based Hong Kong Cardiovascular Risk Factors Prevalence Study, without known diabetes, were included. All had their glycaemic status assessed by OGTT and HbA1c , according to American Diabetic Association 2010 criteria. RESULTS: Based on OGTT criteria alone, 3.5% of the study cohort (N = 1300) had diabetes and 19.2% had prediabetes. Based on HbA1c criteria only, 6.2% had diabetes and 61.2% had prediabetes. The measurement of HbA1c , in addition to the OGTT, increased the proportion of participants with diabetes to 7.8% and with prediabetes to 65.3%. Subjects with prediabetes having raised HbA1c but normal glycaemia (N = 600) had waist circumference, systolic blood pressure, fasting glucose, insulin resistance index (HOMA-IR), Gutt Index and Framingham 10-year cardiovascular risk scores intermediate between those with both normal HbA1c and glycaemia (N = 350), and those with impaired fasting glucose and/or impaired glucose tolerance (N = 249; all P < 0.01). CONCLUSION: The measurement of HbA1c in our population, in addition to the OGTT, results in the detection of a large number of participants with prediabetes having raised HbA1c but normal glycaemia who have a cardiometabolic risk profile intermediate between impaired fasting glucose and/or impaired glucose tolerance and normal participants, and would benefit from early lifestyle intervention.
AIMS: To investigate the usefulness of the additional measurement of HbA1c , compared with performing only the oral glucose tolerance test (OGTT), in identifying participants at increased cardiometabolic risk, in an urban Chinese population. METHODS: All participants from the fourth visit of the population-based Hong Kong Cardiovascular Risk Factors Prevalence Study, without known diabetes, were included. All had their glycaemic status assessed by OGTT and HbA1c , according to American Diabetic Association 2010 criteria. RESULTS: Based on OGTT criteria alone, 3.5% of the study cohort (N = 1300) had diabetes and 19.2% had prediabetes. Based on HbA1c criteria only, 6.2% had diabetes and 61.2% had prediabetes. The measurement of HbA1c , in addition to the OGTT, increased the proportion of participants with diabetesto 7.8% and with prediabetes to 65.3%. Subjects with prediabetes having raised HbA1c but normal glycaemia (N = 600) had waist circumference, systolic blood pressure, fasting glucose, insulin resistance index (HOMA-IR), Gutt Index and Framingham 10-year cardiovascular risk scores intermediate between those with both normal HbA1c and glycaemia (N = 350), and those with impaired fasting glucose and/or impaired glucose tolerance (N = 249; all P < 0.01). CONCLUSION: The measurement of HbA1c in our population, in addition to the OGTT, results in the detection of a large number of participants with prediabetes having raised HbA1c but normal glycaemia who have a cardiometabolic risk profile intermediate between impaired fasting glucose and/or impaired glucose tolerance and normal participants, and would benefit from early lifestyle intervention.
Authors: Yu Cho Woo; Chi Ho Lee; Carol H Y Fong; Annette W K Tso; Bernard M Y Cheung; Karen S L Lam Journal: PLoS One Date: 2017-09-14 Impact factor: 3.240
Authors: Kelvin K K Ng; Chloe Y Y Cheung; Chi-Ho Lee; Carol H Y Fong; Kelvin H M Kwok; Kenneth K W Li; Rita A Gangwani; Ian Y H Wong; Yu-Cho Woo; Wing-Sun Chow; Michele M A Yuen; Rachel L C Wong; Aimin Xu; David S H Wong; Pak-Chung Sham; Karen S L Lam Journal: Invest Ophthalmol Vis Sci Date: 2020-08-03 Impact factor: 4.799
Authors: Weerachai Srivanichakorn; Ian F Godsland; Chaiwat Washirasaksiri; Pochamana Phisalprapa; Phunchai Charatcharoenwitthaya; Pornpoj Pramyothin; Tullaya Sitasuwan; Lukana Preechasuk; Robert Elkeles; K George Mm Alberti; Desmond G Johnston; Nick S Oliver Journal: J Diabetes Investig Date: 2018-11-30 Impact factor: 4.232
Authors: Yu Cho Woo; Bin Gao; Chi Ho Lee; Carol Ho-Yi Fong; David Tak-Wai Lui; Jie Ming; Li Wang; Kristy Man-Yi Yeung; Bernard Man-Yung Cheung; Tai Hing Lam; Edward Janus; Qiuhe Ji; Karen Siu-Ling Lam Journal: J Diabetes Investig Date: 2019-10-01 Impact factor: 4.232